China enters new era in patent protection for plant-related inventions

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

China enters new era in patent protection for plant-related inventions

Sponsored by

ccpit.jpg
Plant shoot in a pot

The revised Patent Examination Guidelines foster innovation by redefining plant varieties, says Juhua Luo of CCPIT Patent and Trademark Law Office

In November 2025, China issued a revised version of its Patent Examination Guidelines, which took effect on January 1 2026. The revision introduces significant changes to the examination standards for patent applications in the field of biological breeding, with particular emphasis on plant-related inventions.

These amendments mark an important step towards strengthening patent protection for innovations in plant breeding and improving coordination between the patent system and the plant variety protection (PVP) regime.

Background and purpose of the amendments

Plant breeding is inherently capital-intensive and time-consuming, with long R&D cycles and high technical risk. Intermediate breeding materials often constitute the essential foundation for developing new plant varieties, but they are highly susceptible to replication and misappropriation. In recent years, the widespread application of transgenic and gene-editing technologies has generated a large number of breeding intermediates with substantial technical and commercial value.

Under the previous version of the Patent Examination Guidelines, however, the scope of plant varieties was defined in such a broad manner that, in practice, it operated to exclude virtually all individual plants and their reproductive materials from patent protection. As a result, many valuable breeding-related innovations fell into a protection gap between the patent system and the PVP regime, undermining incentives for technological investment in the breeding industry.

The current revision seeks to address this long-standing issue by clarifying the definition of plant variety and refining the boundaries of patent-eligible subject matter in the plant breeding field.

Revised definition of plant variety

To remedy the practical over-exclusion caused by the earlier definition, the revised guidelines redefine “plant variety” as a plant population that:

  • Has been artificially bred or discovered and subsequently improved;

  • Exhibits uniform morphological and biological characteristics; and

  • Possesses relatively stable genetic traits.

This population-based definition replaces the earlier formulation, which focused on individual plants and their reproductive materials and effectively precluded patent protection for most plant-related inventions. By contrast, the revised definition limits the concept of plant variety to plant populations that meet clear requirements of uniformity and genetic stability.

Importantly, the revised guidelines align the definition of plant variety with the corresponding definitions under China’s Seed Law and the Regulations on the Protection of New Varieties of Plants. This alignment enhances coherence between the patent system and the PVP regime, reduces regulatory overlap, and helps avoid gaps in intellectual property protection.

In practical terms, the revision narrows the scope of subject matter excluded as plant varieties and creates greater room for patent protection of plant-related technologies that do not constitute specific, uniform, and genetically stable plant populations.

Treatment of naturally occurring wild plants

The revised guidelines further clarify the treatment of naturally occurring wild plants. They explicitly provide that wild plants found in nature, without any technical intervention, constitute scientific discoveries within the meaning of Article 25(1)(1) of the Patent Law and therefore are not eligible for patent protection.

At the same time, the guidelines distinguish such scientific discoveries from situations in which wild plants have been artificially bred or improved and demonstrate industrial applicability. In the latter case, the plant itself is no longer regarded as a mere scientific discovery and may fall within patent-eligible subject matter.

This clarification follows the examination logic already applied to wild micro-organisms and naturally occurring genes or DNA fragments, and it provides clearer guidance for assessing the patent eligibility of plant-related inventions derived from natural resources.

Principles for determining whether claimed subject matter constitutes a plant variety

The revised guidelines set out explicit principles for determining whether claimed subject matter should be regarded as a plant variety. The determination is made based on the technical solution defined in the claims, in light of the disclosure of the application as a whole.

In particular, examiners are instructed to assess whether the claimed plant or its reproductive material, at the population level, exhibits:

  • Uniformity, meaning that the relevant characteristics or traits are consistent among individuals within the population, except for predictable natural variation; and

  • Stability, meaning that the essential traits remain unchanged after repeated propagation or at the end of a specific propagation cycle.

For example, where a claim explicitly seeks protection for a specific plant variety or its reproductive material – such as “a transgenic soybean variety” – the subject matter generally falls within the scope of a plant variety.

By contrast, claims directed to a broad plant population defined primarily by the presence of a particular DNA sequence or functional protein typically do not satisfy the population-level requirements of uniformity and genetic stability and therefore fall outside the concept of a plant variety. For instance, a claim directed to “a drought-resistant rice plant comprising an exogenous gene as shown in SEQ ID NO:1” does not constitute a plant variety.

Transgenic plants under the revised guidelines

Following the narrowing of the plant variety concept, the revised guidelines clarify that a transgenic plant constitutes a plant variety only if it exhibits uniform morphological and biological characteristics and relatively stable genetic traits at the population level.

This clarification has important implications for patent prosecution strategies in agricultural biotechnology. It underscores the need to distinguish between claims directed to specific, stabilised plant varieties and those directed to broader technical solutions involving genetic traits, constructs, or breeding methods.

Practical implications for IP practice

Overall, the amendments significantly strengthen patent protection for technological innovation in the field of plant breeding. As a general rule, plant-related inventions that do not involve a specific plant variety as defined under the PVP regime, and that are not naturally occurring wild plants without technical intervention, may constitute patent-eligible subject matter.

For intellectual property professionals, the revised guidelines highlight the importance of careful claim drafting, strategic coordination between patent protection and plant variety rights, and a nuanced understanding of population-level uniformity and stability. The changes provide greater legal certainty and create a more balanced and innovation-friendly framework for protecting breeding-related technologies in China.

more from across site and SHARED ros bottom lb

More from across our site

Amita Haylock discusses building an integrated Asia practice as clients increasingly demand that firms combine IP, technology and data expertise
François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
Gift this article